| Dr Harish Marisiddaiah, MD | |
|
2711 X Ray Dr, Gastonia, NC 28054-7491 | |
| (704) 834-2465 | |
| (704) 834-2466 |
| Full Name | Dr Harish Marisiddaiah |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 33 Years |
| Location | 2711 X Ray Dr, Gastonia, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073500765 | NPI | - | NPPES |
| 8954784 | Medicaid | NC | |
| N00993 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | MD61064980 (Washington) | Primary |
| 207RI0200X | Internal Medicine - Infectious Disease | 9500993 (North Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Caromont Regional Medical Center | Gastonia, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Caromont Medical Group Inc | 3577476258 | 328 |
News Archive
A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) at the University of Kentucky College of Medicine suggests that your genetics can influence your response to Alzheimer's disease pathology.
The onset of the COVID-19 pandemic led to the imposition of several non-pharmaceutical interventions (NPIs) across the world. While citizens in the USA have been chafing over the advice to wear masks in public, restricted social interactions, and limited attendance at schools, colleges and workplaces, a new study published on the preprint server medRxiv* in November 2020 reports that these NPIs were linked to a steep reduction in the incidence of the non-respiratory pathogen, noroviruses.
"Gilead Sciences Inc. may learn this year whether its drugs for treating HIV can also stop people from catching the virus in the first place," Bloomberg writes in a piece that examines the potential benefits and drawbacks to using low-doses of HIV/AIDS medications to reduce a person's risk of becoming infected with HIV. According to the news service, the initial results of 10 trials including more than 20,000 people could be available as early as July.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
› Verified 1 days ago
| Entity Name | Caromont Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356314272 PECOS PAC ID: 3577476258 Enrollment ID: O20031201000070 |
News Archive
A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) at the University of Kentucky College of Medicine suggests that your genetics can influence your response to Alzheimer's disease pathology.
The onset of the COVID-19 pandemic led to the imposition of several non-pharmaceutical interventions (NPIs) across the world. While citizens in the USA have been chafing over the advice to wear masks in public, restricted social interactions, and limited attendance at schools, colleges and workplaces, a new study published on the preprint server medRxiv* in November 2020 reports that these NPIs were linked to a steep reduction in the incidence of the non-respiratory pathogen, noroviruses.
"Gilead Sciences Inc. may learn this year whether its drugs for treating HIV can also stop people from catching the virus in the first place," Bloomberg writes in a piece that examines the potential benefits and drawbacks to using low-doses of HIV/AIDS medications to reduce a person's risk of becoming infected with HIV. According to the news service, the initial results of 10 trials including more than 20,000 people could be available as early as July.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harish Marisiddaiah, MD 2240 Remount Rd, Gastonia, NC 28054-4725 Ph: (704) 671-5311 | Dr Harish Marisiddaiah, MD 2711 X Ray Dr, Gastonia, NC 28054-7491 Ph: (704) 834-2465 |
News Archive
A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) at the University of Kentucky College of Medicine suggests that your genetics can influence your response to Alzheimer's disease pathology.
The onset of the COVID-19 pandemic led to the imposition of several non-pharmaceutical interventions (NPIs) across the world. While citizens in the USA have been chafing over the advice to wear masks in public, restricted social interactions, and limited attendance at schools, colleges and workplaces, a new study published on the preprint server medRxiv* in November 2020 reports that these NPIs were linked to a steep reduction in the incidence of the non-respiratory pathogen, noroviruses.
"Gilead Sciences Inc. may learn this year whether its drugs for treating HIV can also stop people from catching the virus in the first place," Bloomberg writes in a piece that examines the potential benefits and drawbacks to using low-doses of HIV/AIDS medications to reduce a person's risk of becoming infected with HIV. According to the news service, the initial results of 10 trials including more than 20,000 people could be available as early as July.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
› Verified 1 days ago
Louise Zhou, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2711 X Ray Dr Ste 3701, Gastonia, NC 28054 Phone: 980-834-9600 Fax: 980-834-9605 | |
Anthony R Arn, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2555 Court Dr, Suite 300, Gastonia, NC 28054 Phone: 704-868-3256 Fax: 704-868-5870 | |
Douglas A Nigbor, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2544 Court Dr, Ste F, Gastonia, NC 28054 Phone: 704-864-8302 Fax: 704-864-0228 | |
Ajaykumar Narandas Patel, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2525 Court Dr, Gastonia, NC 28054 Phone: 704-834-2000 Fax: 704-834-2500 | |
Dr. Yi Zhang, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2544 Court Dr Ste F, Gastonia, NC 28054 Phone: 704-864-8302 Fax: 704-864-0228 | |
Dr. Shawnya Ayers Gore, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1867 Remount Rd, Suite D, Gastonia, NC 28054 Phone: 704-854-8799 Fax: 704-854-8803 | |
Richard Alan Fricker, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2240 Remount Rd, Gastonia, NC 28054 Phone: 704-671-5344 Fax: 704-671-5331 |